Reporting by Karolina Tagaris, Angeliki Koutantou; editing by James MackenzieOur Standards: The Thomson Reuters Trust Principles. Gruber anticipates data from those trials will likely be available "late at the end of the year or beginning of 2022." However, he said Pfizer has data that indicates a fully-vaccinated person's current dosage could be highly effective "at least up to 6 months," and possibly more. "We obviously are very attentive to being deliberate and careful, as we move down in age," he said. He said it presented "an opportunity to get back to normal life."
The Thomson Reuters faithfulness for publication is up in the trial in 2019.
( z0 try :ARG1 ( z1 faith :purpose ( z2 publish ) :poss ( z3 publication :name ( z4 name :op "Thomson" :op "Reuters" ) ) ) :time ( z5 date-entity :year 2019 ) )
(z0 / try-02
    :ARG1 (z1 / faith
              :purpose (z2 / publish-01)
              :poss (z3 / publication
                        :name (z4 / name
                                  :op1 "Thomson"
                                  :op2 "Reuters")))
    :time (z5 / date-entity
              :year 2019))
The Thomson Reuters faithfulness for publication is up in the trial in 2019 .
z4 :op1 2
z3 :name z4
z4 :op2 1
z1 :poss z3
z1 :purpose z2
z0 :ARG1 z1
z0 :time z5
z5 :year 0